Fentanyl patch absorption in ICU patients
Part of Brain & nervous system clinical trials.
This study looks at how well fentanyl patches work in ICU patients who are not stable. It aims to understand if the patch is absorbed properly in these patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must be admitted to the surgical ICU.
- You need pain relief that requires fentanyl treatment.
- You cannot have allergies to fentanyl.
- You cannot have severe constipation or liver failure.
- You cannot be on very high doses of blood pressure medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the sedative remifentanil works in critically ill patients who are underweight or normal weight. It aims to find the right dose for these patients while they are on a breathing machine in the ICU.
This study looks at a new way to measure pain in ICU patients who are on a breathing machine (ventilator) and receiving strong pain medicine (opioids). The goal is to see if adjusting pain medicine based on a special pain assessment tool can improve comfort and recovery.
This study compares two different pain and sedation medicines (fentanyl and morphine) given continuously through an IV to help patients who are on a breathing machine (ventilator) in the ICU. The goal is to see which medicine works better and is safer for keeping you comfortable and calm.
This trial tests a nebulized (inhaled mist) form of fentanyl in healthy volunteers to see how it works in the body. It is a first-in-human study of the drug given through a nebulizer, which might help people with acute pain in the future.
This trial is testing a new way to give fentanyl under the skin for cancer-related pain. The goal is to find the right dose quickly and safely to make sure you get enough pain relief.
This study tests a new drug, CS-1103, to see if it can safely help reverse the effects of fentanyl (a strong opioid) even after a naloxone block. Healthy volunteers who have used opioids before will be given fentanyl and then the study drug, while researchers monitor safety and how the drug works.
Hear when a new Pain Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.